Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Pharmaceuticals (Basel, Switzerland)|December 23, 2022
Progranulin in Musculoskeletal Inflammatory and Degenerative Disorders, Focus on Rheumatoid Arthritis, Lupus and Intervertebral Disc Disease: A Systematic ReviewMaría González-Rodríguez, Djedjiga Ait Edjoudi, Alfonso Cordero Barreal, et al.
Frontiers in Endocrinology|January 23, 2023
Asprosin in health and disease, a new glucose sensor with central and peripheral metabolic effectsMariam Farrag, Djedjiga Ait Eldjoudi, María González-Rodríguez, et al.
Arthritis Research & Therapy|October 5, 2023
Assessment of anti-malondialdehyde-acetaldehyde antibody frequencies in rheumatoid arthritis with new data from two independent cohorts, meta-analysis, and meta-regressionLorena Rodriguez-Martinez, Cristina García-Moreno, Eva Perez-Pampin, et al.
Seminars in Arthritis and Rheumatism|September 13, 2020
Association of serum anti-centromere protein F antibodies with clinical response to infliximab in patients with rheumatoid arthritis: A prospective studyLucía Lourido, Cristina Ruiz-Romero, Flor Picchi, et al.
The Pharmacogenomics Journal|March 10, 2018
Evaluation of a clinical pharmacogenetics model to predict methotrexate response in patients with rheumatoid arthritisRosario López-Rodríguez, Aida Ferreiro-Iglesias, Aurea Lima, et al.
Annals of the Rheumatic Diseases|August 16, 2020
Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort studyJose L Pablos, María Galindo, Loreto Carmona, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 28, 2022
WISP-2 modulates the induction of inflammatory mediators and cartilage catabolism in chondrocytesClara Ruiz-Fernández, María González-Rodríguez, Vanessa Abella, et al.
Annals of the Rheumatic Diseases|June 14, 2020
Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseasesJose L Pablos, Lydia Abasolo, Jose M Alvaro-Gracia, et al.
Reumatologia Clinica|July 6, 2025
One-year retention rate of ixekizumab in patients with psoriatic arthritis and axial spondyloarthritis: Real-world data from the BIOBADASER registryClementina López-Medina, Lucía Otero-Varela, Fernando Sánchez-Alonso, et al.
Rheumatology (Oxford, England)|October 22, 2025
Cancer risk in patients with rheumatoid arthritis receiving biologic and targeted synthetic disease modifying antirheumatic drugs: results from the BIOBADASER III registryJuan Molina-Collada, Lucía Otero-Varela, Paloma Vela, et al.
Pageof 7